Impact BioMedical Inc. (IBO) stock
IBONYSEPharmaceutical PreparationsFiscal year ends December 31
$3.06+0.38 (+14.18%)
Close on Oct 19, 2026Market cap $329.93MP/E –Yield –
Impact BioMedical revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Impact BioMedical's revenue for the twelve months ending Jun 30, 2026 was $35.00K. For fiscal 2025 it was $32.00K, down 36.0% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $32.00K | -36.0% |
| FY2022 | Dec 31, 2022 | $50.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.00K | -57.1% |
| Q1 FY2026 | Mar 31, 2026 | $7.00K | – |
| Q4 FY2025 | Dec 31, 2025 | $7.00K | – |
| Q3 FY2025 | Sep 30, 2025 | $18.00K | -64.0% |
| Q2 FY2025 | Jun 30, 2025 | $7.00K | – |
| Q4 FY2022 | Dec 31, 2022 | $0 | – |
| Q3 FY2022 | Sep 30, 2022 | $0 | – |
| Q2 FY2022 | Jun 30, 2022 | $50.00K | – |
See a number that looks wrong?